How many Chinese players are active in the U.S. injectable market? Or put it other way around, how many of the front -end companies source their raw -- source their finished injectable products from Chinese manufacturing plant. If you can give some colour -- this is in context with the tariff thing which we spoke earlier.
And when we see our top 10 or top 25 products, such kind of Chinese sourcing or Chinese competitors? Would there be -- would there be a decent -- would they have a decent volume market share, like -- and with this tariff, things can swing in coming quarters? Is that a probable scenario?